Trial Profile
Gadolinium Enhanced Dual-Energy Computed Tomography: A Feasibility Study to Assess Image Quality and Diagnostic Confidence
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 06 May 2021
Price :
$35
*
At a glance
- Drugs Gadofosveset (Primary)
- Indications Diagnostic-imaging-abnormalities
- Focus Diagnostic use
- 29 Apr 2021 Status changed from not yet recruiting to withdrawn prior to enrolment. No patients enrolled as study did not move to enrollment stage.
- 27 Sep 2016 Planned initiation date changed from 1 Mar 2015 to 1 Dec 2016.
- 28 Jan 2015 Planned initiation date changed from 1 Aug 2014 to 1 Mar 2015 as reported by ClinicalTrials.gov.